Grace Therapeutics, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 16, 2026 (21 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 24, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Feb 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
No cross-platform signals in the last 90 days